Andrew D Rhim MD University of Michigan Medical School Clinical Case 72yo man presents to General GI clinic for abdominal discomfort after eating Developed over the past 89 months Vague dull discomfortpressure starting 1020 minutes after eating and lasting for 30min to a few hours ID: 919122
Download Presentation The PPT/PDF document "Pancreatic Cancer: Case and Discussion" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Pancreatic Cancer: Case and Discussion
Andrew D. Rhim, MD
University of Michigan
Medical School
Slide2Clinical Case
72yo man presents to General GI clinic for abdominal discomfort after eating
Developed over the past 8-9 months
Vague, dull discomfort/pressure starting 10-20 minutes after eating and lasting for 30min to a few hours
Does not interfere with daily activities (2-3/10)
Located in the
epigastrum
, MAYBE radiating to his back
Not eating helps, though he has been careful to maintain caloric intake
Slide3HPI
72yo man presents to General GI clinic for abdominal discomfort after eating
No associated nausea, vomiting, diarrhea or constipation
Has noted 20lb weight loss in the past 2-3 months, though he denies anorexia
Denies new-onset depression, jaundice, malaise
Has noted increased urination and thirst (maybe)
Slide4Review of Systems
Constitutional: Positive for unexpected weight change. Negative for fever, chills, diaphoresis, activity change, appetite change and fatigue.
HENT: Negative.
Eyes: Negative.
Respiratory: Positive for apnea and cough. Negative for choking, chest tightness, shortness of breath, wheezing and stridor.
Cardiovascular: Negative.
Gastrointestinal: Positive for abdominal pain. Negative for nausea, vomiting, diarrhea, constipation, blood in stool, abdominal distention, anal bleeding and rectal pain.
Endocrine: Negative.
Genitourinary: Negative.
Musculoskeletal: Negative.
Skin: Negative.
Allergic/Immunologic: Negative.
Neurological: Negative.
Hematological: Negative.
Psychiatric/Behavioral: Negative.
(No depression)
Slide5Past Medical History
History of colon cancer 10 years ago, in remission after colectomy.
GERD
HTN
COPD (previous smoker)
Cataracts
Diabetes mellitus II
Diagnosed 6 months ago
Recent requirement of insulin 2 weeks ago
Slide6Social History
Previous smoker—quit 2011
EtOH
—4 cans a week, denies history of binging
No IVDA
Married with 3 grown children
Retired school teacher
Slide7Family history
Colon cancer in father (60)
Unknown cancer in mother, sister, maternal aunt, maternal uncle.
Slide8Physical Exam
Constitutional: He is oriented to person, place, and time. He appears well-developed and well-nourished. No distress.
HENT:
Normal
Head:
Normocephalic
and
atraumatic
.
Nose: Nose normal.
Mouth/Throat: No
oropharyngeal
exudate.
Eyes: Conjunctivae are normal. Pupils are equal, round, and reactive to light. Right eye exhibits no discharge. Left eye exhibits no discharge. No scleral icterus.
Neck: Neck supple. No tracheal deviation present.
Cardiovascular: Intact distal pulses.
Pulmonary/Chest: Effort normal and breath sounds normal. No stridor. No respiratory distress. He has no wheezes.
Abdominal: Soft.
Nl
bowel sounds. He
exhibits no
distention
. There is no guarding.
Musculoskeletal
: Normal range of motion. He exhibits no edema.
Neurological
: He is alert and oriented to person, place, and time. No cranial nerve deficit. Coordination normal.
Skin: Skin is warm and dry. No rash noted. He is not diaphoretic. No erythema. No
pallor or jaundice
Psychiatric
: He has a normal mood and affect. His behavior is normal. Judgment and thought content normal.
Slide9Labs
144
4.3
98
30
10
0.98
241
1.0
31.5
4.4
14.8
365
ALT = 37
AST = 36
TBili
=
1.6
Alk
Phos
= 99
Alb
= 4.1
Slide10CT abdomen/pelvis
Pancreas:
Atrophy of body and tail of pancreas
Dilated main pancreatic duct with transition point, with no obvious mass lesion
Remainder of the pancreas appears normal
No lymph node enlargement or other masses.
Exam otherwise normal
Slide11Slide12Next steps?
Repeat cross sectional imaging (MRCP)
Endoscopic ultrasound +/- FNA
EGD + colonoscopy
Treat patient for IBS
Pancreatic enzyme supplementation
Slide13Next steps?
Repeat cross sectional imaging (MRCP)
Endoscopic ultrasound +/- FNA
EGD + colonoscopy
Treat patient for IBS
Pancreatic enzyme supplementation
Slide14Why? High suspicion for neoplasm
HPI:
Vague
, dull discomfort/pressure
starting 10-20 minutes after eating and lasting for 30min to a few hours
Located
in the
epigastrum
, MAYBE radiating to his back
Has noted
20lb
weight loss
in the past 2-3 months, though he denies anorexia
Denies new-onset depression, jaundice, malaise
Has noted
increased urination and thirst
Slide15Why? High suspicion for neoplasm
PMH
Diabetes mellitus II
Diagnosed 6 months ago
Recent requirement of insulin 2 weeks ago
Labs:
Fasting glucose
elevated
CT pancreas:
Abrupt cut-off of pancreatic duct
Atrophy of distal pancreas
Slide16Mass in body of pancreas
Diagnosis:
Pancreatic ductal adenocarcinoma,
Stage 1
Treatment:
Surgical resection +
Adjuvant chemo
Slide17Pancreatic Cancer Epidemiology
Incidence: 11.7 per 100,000
Rising incidence
6.7% increase 1995
2005
Lifetime risk: 1.41%
1 in 71 Americans will be diagnosed w/ PC
Median age of diagnosis: 72
Median age of death: 73
SEER, 2009
Slide18Pancreatic Cancer: An Imminent Threat
Matrisian,
Cancer Res
2014
Slide19Pancreatic Cancer: Poor survival due to metastatic disease
5 year survival from diagnosis: <5
% (all-comers)
80% will present with invasive and metastatic disease at
diagnosis
Even with chemotherapy, median survival is ~6mo
20% will present with limited primary tumors with no metastatic disease
Most of these patients will undergo surgical
resection
Slide20Surgical Treatment
Only chance at cure
Only indicated for patients with:
Limited tumor burden
No evidence of
mets
Satisfactory surgical risk
Whipple procedure v. distal
Relatively high morbidity
Post-op infection, leaks, bleeding
Brittle diabetes
Malnutrition and weight loss
Adjuvant
chemtherapy
recommended
Slide21Poor survival even after surgery
Even
without clinical evidence of metastasis, 5y survival after resection is
poor (~20%)
Even with small tumors
Mostly due to metastatic
disease
Agarwal et al., Pancreas 2008
Slide22Early warning signs of PDAC
Abrupt onset of diabetes in non-obese individuals over the age of 60
OR sudden insulin requirements or erratic blood sugar control
Depression
Evidence of pancreatic exocrine insufficiency
Foul smelling, floating stools
Malabsorption
Weight loss despite sufficient caloric intake
Non-specific symptoms:
Malaise, weight loss, anorexia, dull abdominal discomfort
Diagnostic test: pancreas protocol CT scan + IV contrast (though MR may be better)
Slide23High risk groups
Chronic pancreatitis
Especially hereditary pancreatitis
Familial pancreatic cancer
≥2 first degree relatives with PDAC
Other genetic syndromes
Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM; 38-fold increased risk)
Peutz-Jeghers
Syndrome (36% lifetime risk)
BRCA 2 mutation
Cystic fibrosis?
Screening: alternating annual EUS + MRI/CT
Slide24Conclusions
Pancreatic cancer is a horrible disease
Median survival of 6-8mo
Will soon be the second leading cause of cancer-related deaths in the US
While not perfect, there are “early” warning signs
Abrupt onset diabetes, weight loss, depression
Surgery is the only treatment that may lead to durable cure at this point in time (~20% live to 5y)